Karl Storz Acquires U.K.-Based AI Software Company Innersight Labs
Karl Storz announced on January 10 the acquisition of Innersight Labs, headquartered in London. Innersight Labs is a British company founded in 2015. The company developed Innersight3D, a software-only product that allows surgeons to create a patient-specific 3D model from a medical CT or MRI scan. ISL labels the received scans according to different tissue types and creates an interactive 3D model that can be accessed and interacted with via a web link sent to the physician. Karl Storz is a German medical device company that manufactures and sells endoscopes and surgical instruments. It was founded in Tuttlingen, Germany by Dr. Karl Storz in 1945. The company is privately... Read More »
4DMedical Merges with Imbio
4DMedical Limited announced the creation of a comprehensive cardiothoracic image analysis portfolio with the acquisition of Imbio. Imbio is a leader in artificial intelligence medical imaging solutions for chronic lung and cardiothoracic diseases. Imbio’s regulatory cleared solutions transform the way patients are discovered, diagnosed and treated. It was a portfolio company of Invenshure, a biotechnology organization based in Minneapolis, Minnesota. 4DMedical Limited is a global medical technology company that has created a step change in the capacity to understand the lung function of patients with respiratory diseases. Through its flagship patented XV Technology®,... Read More »
imaware Acquires binx health’s Assets
On December 5, imaware announced that it entered into an agreement to acquire binx health’s at-home consumer testing business. binx health is a healthcare technology and diagnostics company focused on innovating solutions to improve routine testing and convenience. Founded in 2005, it is based in Boston, Massachusetts and has an office in Bath, United Kingdom. imaware is a digital health platform company powering home-testing for healthcare brands. Its technology solutions provide patients, providers, employers and brands with access to a digitally-native care model. The model includes logistics, CLIA/CAP-certified laboratory analysis, telehealth support and... Read More »
New Mountain Capital-Backed PerkinElmer Acquires Covaris
PerkinElmer, backed by New York-based private equity firm New Mountain Capital, announced on December 4 that it has acquired Covaris. According to data in the LevinPro HC database, this transaction marks the 118th Laboratories, MRI and Dialysis acquisition of 2023, and 27th in the laboratories specialty. Covaris, also majority-owned by New Mountain Capital, provides tools and technologies to improve pre-analytical sample preparation, enable novel drug formulations and manage compounds in the drug discovery process. The company was founded in 1999 in Woburn, Massachusetts. PerkinElmer provides products and services to the diagnostics, research, environmental, industrial and... Read More »
